AJMC articleshttps://www.ajmc.com/newsAJMC articles© 2026 MJH Life Sciences™ and AJMC. All rights reserved.Sun, 20 Sep 2026 08:50:48 +00005en-us14447https://www.ajmc.com/newshttps://www.ajmc.com/logo.webphttps://www.ajmc.com/view/regorafenib-prescribing-in-advanced-gist-deviates-from-guidelineshttps://www.ajmc.com/view/regorafenib-prescribing-in-advanced-gist-deviates-from-guidelines<![CDATA[Claims data show regorafenib is prescribed earlier than guidelines advise for a good share of patients with advanced GIST, with dosing also varying widely.]]>Sat, 19 Sep 2026 14:27:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/secondary-t-cell-cancers-after-car-t-rare-real-and-worth-watchinghttps://www.ajmc.com/view/secondary-t-cell-cancers-after-car-t-rare-real-and-worth-watching<![CDATA[However, the risk of these rare cancers is not enough to dissuade prescribing CAR T-cell therapy for CLL, explains Kerry Rogers, MD, The James.]]>Sat, 19 Sep 2026 12:00:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/vitamin-k-refusals-are-rising-what-payers-need-to-knowhttps://www.ajmc.com/view/vitamin-k-refusals-are-rising-what-payers-need-to-know<![CDATA[Vitamin K shot refusals rose 77% from 2017 to 2024. Experts break down the drivers, risks, and how clinicians and payers should respond in 5 FAQs.]]>Fri, 18 Sep 2026 21:19:49 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/oral-glp-1s-medicare-bridge-reshape-obesity-care-holly-lofton-mdhttps://www.ajmc.com/view/oral-glp-1s-medicare-bridge-reshape-obesity-care-holly-lofton-md<![CDATA[Oral GLP-1s, Medicare access, and lingering weight bias are reshaping obesity care, says NYU Langone's Holly Lofton, MD.]]>Fri, 18 Sep 2026 21:06:38 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/b-cell-signature-may-flag-who-clears-hbsag-after-stopping-hepatitis-b-therapyhttps://www.ajmc.com/view/b-cell-signature-may-flag-who-clears-hbsag-after-stopping-hepatitis-b-therapy<![CDATA[Activated memory B cells were already enriched at treatment end in the 5 of 21 patients who later cleared HBsAg]]>Fri, 18 Sep 2026 21:04:26 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/why-equity-should-guide-cancer-care-investment-karen-van-caulil-phdhttps://www.ajmc.com/view/why-equity-should-guide-cancer-care-investment-karen-van-caulil-phd<![CDATA[Karen van Caulil, PhD, on how employers can improve cancer care by investing in access, prevention, and support through treatment and survivorship.]]>Fri, 18 Sep 2026 20:48:34 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/specialty-pharmacy-leaders-to-convene-for-nasp-inspire2026https://www.ajmc.com/view/specialty-pharmacy-leaders-to-convene-for-nasp-inspire2026<![CDATA[Specialty pharmacy leaders will gather in National Harbor for inSPire2026, tackling cell and gene therapy access, AI, and high-cost drug pricing.]]>Fri, 18 Sep 2026 19:12:16 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/ai-can-ease-administrative-burden-in-community-oncologyhttps://www.ajmc.com/view/ai-can-ease-administrative-burden-in-community-oncology<![CDATA[Debra Patt, MD, PhD, MBA, MPH, discusses AI adoption, administrative burden, and strategies to streamline prior authorization in oncology.]]>Fri, 18 Sep 2026 18:33:15 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/health-equity-access-weekly-roundup-september-18-2026https://www.ajmc.com/view/health-equity-access-weekly-roundup-september-18-2026<![CDATA[ERS spotlights AI lung disease detection; employer cancer benefits; outpatient CAR T; tafasitamab response similar across races; HFpEF missed at referral.]]>Fri, 18 Sep 2026 17:55:47 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/j-j-oncology-care-index-finds-community-innovation-adoption-gaphttps://www.ajmc.com/view/j-j-oncology-care-index-finds-community-innovation-adoption-gap<![CDATA[J&amp;J's Oncology Care Index finds a systems problem, not a confidence gap, in community oncology, Mahadi Baig, MD, says.]]>Fri, 18 Sep 2026 17:10:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/bundled-payments-bring-cost-predictability-robert-baird-rn-msahttps://www.ajmc.com/view/bundled-payments-bring-cost-predictability-robert-baird-rn-msa<![CDATA[Bundled payment models offer employers and community oncology practices greater cost predictability while improving patient access, Baird said.]]>Fri, 18 Sep 2026 17:00:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/look-beyond-single-use-prior-authorization-solutions-jeff-hunnicutthttps://www.ajmc.com/view/look-beyond-single-use-prior-authorization-solutions-jeff-hunnicutt<![CDATA[Jeff Hunnicutt emphasized vetting prior authorization vendors, scaling beyond single use cases, and AI's potential to streamline workflows. ]]>Fri, 18 Sep 2026 15:25:35 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/higher-cpap-adherence-linked-with-lower-mortality-risk-in-osahttps://www.ajmc.com/view/higher-cpap-adherence-linked-with-lower-mortality-risk-in-osa<![CDATA[Each additional hour of nightly CPAP use was associated with 13% lower all-cause mortality risk in a French cohort of adults with sleep apnea.]]>Fri, 18 Sep 2026 14:56:14 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/endometriosis-linked-to-persistent-rise-in-mental-health-medication-usehttps://www.ajmc.com/view/endometriosis-linked-to-persistent-rise-in-mental-health-medication-use<![CDATA[A 20-year Danish registry study found higher antidepressant and anxiolytic use among women with endometriosis, both before and after diagnosis.]]>Fri, 18 Sep 2026 14:54:22 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/nearly-a-third-with-private-insurance-are-paying-off-medical-debthttps://www.ajmc.com/view/nearly-a-third-with-private-insurance-are-paying-off-medical-debt<![CDATA[Working-age adults with private insurance are paying off medical debt, often draining savings, delaying care, or cutting back on necessities as a result.]]>Fri, 18 Sep 2026 14:49:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/ai-imaging-and-smarter-screening-drive-early-lung-disease-detectionhttps://www.ajmc.com/view/ai-imaging-and-smarter-screening-drive-early-lung-disease-detection<![CDATA[AI-assisted spirometry, imaging biomarkers, and population screening strategies highlighted early detection and prevention as a throughline at the ERS Congress.]]>Fri, 18 Sep 2026 14:00:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/ajmc-in-the-press-september-18-2026https://www.ajmc.com/view/ajmc-in-the-press-september-18-2026<![CDATA[Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.]]>Fri, 18 Sep 2026 13:00:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/matching-patient-to-medication-final-perspectives-on-adjunctive-antipsychotic-therapy-in-mddhttps://www.ajmc.com/view/matching-patient-to-medication-final-perspectives-on-adjunctive-antipsychotic-therapy-in-mdd<![CDATA[Led by the moderator, the panelists/expert mental health experts examined key patient-level factors driving selection among the five adjunctive agents — including weight status, sleep disturbance, and general medication sensitivity — with Wilkinson noting a preference for lumateperone given its lack of weight gain and quetiapine for patients needing help with sedation who aren't already overweight, while Bhide observed these are exactly the clinical factors payers would want documented under utilization management.]]>Fri, 18 Sep 2026 12:05:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/comparing-safety-across-the-class-tolerability-trade-offs-and-durability-of-responsehttps://www.ajmc.com/view/comparing-safety-across-the-class-tolerability-trade-offs-and-durability-of-response<![CDATA[Led by the moderator, the expert mental health experts examined network meta-analysis data comparing weight gain and akathisia across the five agents, with Rhee noting lumateperone did not differ from placebo on weight gain while the other four agents showed increased risk, and cautioning that these exploratory findings warrant careful interpretation given limited clinical data.]]>Fri, 18 Sep 2026 12:00:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/glp-1-receptor-agonists-cut-ascites-mortality-in-mashhttps://www.ajmc.com/view/glp-1-receptor-agonists-cut-ascites-mortality-in-mash<![CDATA[Ultimately, causality could not be established due to lack of data on disease severity and socioeconomic status, among others.]]>Thu, 17 Sep 2026 21:30:28 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/hepatitis-a-vaccine-prevents-96-of-infections-given-before-exposurehttps://www.ajmc.com/view/hepatitis-a-vaccine-prevents-96-of-infections-given-before-exposure<![CDATA[GRADE meta-analysis: hepatitis A vaccine blocks 96% in pre-exposure vaccination; outbreak response uses millions of doses, but post-exposure prophylaxis evidence is weak.]]>Thu, 17 Sep 2026 21:08:11 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/employer-benefits-should-reflect-workforce-needs-rosa-novohttps://www.ajmc.com/view/employer-benefits-should-reflect-workforce-needs-rosa-novo<![CDATA[Rosa Novo discusses tailoring cancer benefits to workforce needs, improving access and prevention, and return-to-work support. ]]>Thu, 17 Sep 2026 20:49:14 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/twice-yearly-cd19-therapy-targets-mg-root-cause-richard-nowak-md-mshttps://www.ajmc.com/view/twice-yearly-cd19-therapy-targets-mg-root-cause-richard-nowak-md-ms<![CDATA[Inebilizumab's twice-yearly CD19 dosing directly targets antibody-producing cells; trial enrollment used disease activity, not treatment failure.]]>Thu, 17 Sep 2026 20:48:33 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/alcohol-abuse-tops-list-of-post-trauma-cardiovascular-riskshttps://www.ajmc.com/view/alcohol-abuse-tops-list-of-post-trauma-cardiovascular-risks<![CDATA[Alcohol abuse was the strongest post-trauma psychiatric predictor of cardiovascular events, with mood disorders more prominent among women.]]>Thu, 17 Sep 2026 20:38:46 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/balancing-antibiotic-efficacy-and-c-diff-risk-keith-kaye-md-mphhttps://www.ajmc.com/view/balancing-antibiotic-efficacy-and-c-diff-risk-keith-kaye-md-mph<![CDATA[Keith Kaye, MD, MPH, explains how shorter antibiotic courses and optimized dosing help balance treatment efficacy against C. diff risk.]]>Thu, 17 Sep 2026 20:25:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/meeting-patients-where-they-are-at-in-cancer-care-amanda-green-mphhttps://www.ajmc.com/view/meeting-patients-where-they-are-at-in-cancer-care-amanda-green-mph<![CDATA[Employers can advance patient-centered oncology care through proactive benefits, quality data, navigation, and tailored support, Amanda Green, MPH, said.]]>Thu, 17 Sep 2026 20:13:47 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/why-ers-congress-matters-for-respiratory-care-clinicianshttps://www.ajmc.com/view/why-ers-congress-matters-for-respiratory-care-clinicians<![CDATA[Experts at ERS Congress 2026 discuss why attending respiratory conferences drives learning, networking, and better patient outcomes.]]>Thu, 17 Sep 2026 19:38:02 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/expanding-access-to-car-t-cell-therapy-bispecific-antibodies-swarup-kumar-mdhttps://www.ajmc.com/view/expanding-access-to-car-t-cell-therapy-bispecific-antibodies-swarup-kumar-md<![CDATA[Swarup Kumar, MD, emphasizes that preparation is central to positive outcomes and includes patient education and early intervention when needed.]]>Thu, 17 Sep 2026 18:09:00 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/strength-training-not-linked-to-ventricular-arrhythmia-in-acmhttps://www.ajmc.com/view/strength-training-not-linked-to-ventricular-arrhythmia-in-acm<![CDATA[Individuals with or at risk for arrhythmogenic cardiomyopathy had no added risk of ventricular arrhythmia from strength training, unlike endurance exercise.]]>Thu, 17 Sep 2026 17:11:23 GMTAJMCusAJMC Articleshttps://www.ajmc.com/view/employment-masks-work-burden-of-narcolepsy-and-hypersomniahttps://www.ajmc.com/view/employment-masks-work-burden-of-narcolepsy-and-hypersomnia<![CDATA[A systematic review finds people with narcolepsy and idiopathic hypersomnia often stay employed but face work impairment and limited workplace support.]]>Thu, 17 Sep 2026 15:39:00 GMTAJMCusAJMC Articles